Amino Acid Metabolism

Total Page:16

File Type:pdf, Size:1020Kb

Amino Acid Metabolism Amino acid metabolism The important reaction commonly employed in the breakdown of an amino acid is always the removal of its -amino group. The product ammonia is excreted after conversion to urea or other products and the carbon skeleton is degraded to CO2 releasing energy. Metabolism of amino acids differs, but 3 common reactions: – Transamination – Deamination – Decarboxylation Transamination In transamination • Amino acids are degraded in the liver. • An amino group is transferred from an amino acid to an -keto acid, usually -ketoglutarate. • The reaction is catalyzed by a transaminase or aminotransferase. • • A new amino acid, usually glutamate, and a new -keto acid are formed. 2 Transamination reactions Enzymatic Transamination • Typically, -ketoglutarate accepts amino groups • L-Glutamine acts as a temporary storage of nitrogen • L-Glutamine can donate the amino group when needed for amino acid biosynthesis • All aminotransferases rely on the pyridoxal phosphate cofactor Amino Group Transfer - Aminotransferase Enzymatic removal of -amino groups (transaminase /aminotransferases - named for amino donor i.e. Ala aminotranferase removes amino group from Ala) • Ping-pong kinetics of aspartate (next slide) transaminase (from previous slide) Transamination COO COO CH2 CH2 CH3 CH2 CH3 CH2 + + HC NH3 + C O C O + HC NH3 COO COO COO COO alanine -ketoglutarate pyruvate glutamate Aminotransferase (Transaminase) The 3-C -keto acid pyruvate is produced from alanine, cysteine, glycine, serine, & threonine. Alanine deamination via Transaminase directly yields pyruvate. COO COO COO CH2 COO CH2 CH2 CH2 CH2 CH2 + + HC NH3 + C O C O + HC NH3 COO COO COO COO aspartate -ketoglutarate oxaloacetate glutamate Aminotransferase (Transaminase) The 4-C Krebs Cycle intermediate oxaloacetate is produced from aspartate & asparagine. Aspartate transamination yields oxaloacetate. Aspartate is also converted to fumarate in Urea Cycle. Fumarate is converted to oxaloacetate in Krebs cycle. The Amino Group is Removed From All Amino Acids First Oxidative Deamination Oxidative deamination • Removes the amino group as an ammonium ion from glutamate. • Provides -ketoglutarate for transamination. 12 Oxidative Deamination • Glutamate formed by transamination reactions is deaminated to -ketoglutarate • Glutamate dehydrogenase - NAD+ or NADP+ is coenzyme • Other AA oxidases - (liver, kidney) low activity + NH3 H2 H2 OOC C C C COO glutamate Glutamate H NAD(P)+ Dehydrogenase H2O catalyzes a major NAD(P)H reaction that O H2 H2 + effects net OOC C C C COO + NH4 removal of N -ketoglutarate from the amino Glutamate Dehydrogenase acid pool. It is one of the few enzymes that can use NAD+ or NADP+ as e acceptor. Oxidation at the -carbon is followed by hydrolysis, + releasing NH4 . + Amino acid -ketoglutarate NADH + NH4 + -keto acid glutamate NAD + H2O Transaminase Glutamate Dehydrogenase Summarized above: The role of transaminases in funneling amino N to glutamate, which is deaminated via Glutamate + Dehydrogenase, producing NH4 . Non-oxidative deamination • Amino acids such as serine and histidine are deaminated non-oxidatively • The other reactions involved in the catabolism of amino acids are decarboxylation, • transulfuration, desulfuration, dehydration etc. DEAMIDATION • The amino acid, which contains an amide linkage with ammonia at the γ-carboxyl, degraded by process of deamidation. • E.g, conversion of asparagine to aspartate by removal of alpha amino group. Decarboxylation The decarboxylation process is important since the products of decarboxylation • reactions give rise to physiologically active amines. The enzymes, amino acid decarboxylases are pyridoxal phosphate dependent enzymes. • Pyridoxal phosphate forms a Schiff's base with the amino acid so as to stabilise the -carbanion formed by the cleavage of bond between carboxyl and -carbon • atom. • • The physiologically active amines epinephrine, nor-epinephrine, dopamine, • serotonin, -amino butyrate and histamine are formed through decarboxylation of the corresponding precursor amino acids. Transmethylation • Resynthesis of methionine: • Homocysteine accepts a methyl group from N5- methyltetrahydrofolate (N5-methyl-THF) requiring methylcobalamin, a coenzyme derived from vitamin B12. • • The methyl group is transferred from the B12 derivative to homocysteine, and cobalamin is • recharged from N5-methyl-THF. Excretory Forms of Nitrogen Fate of Individual Amino Acids • Seven to acetyl-CoA – Leu, Ile, Thr, Lys, Phe, Tyr, Trp • Six to pyruvate – Ala, Cys, Gly, Ser, Thr, Trp • Five to -ketoglutarate – Arg, Glu, Gln, His, Pro • Four to succinyl-CoA – Ile, Met, Thr, Val • Two to fumarate – Phe, Tyr • Two to oxaloacetate – Asp, Asn Summar y of Amino Acid Cataboli sm NITROGEN BALANCE Nitrogen balance = nitrogen ingested - nitrogen excreted (primarily as protein) (primarily as urea) Nitrogen balance = 0 (nitrogen equilibrium) protein synthesis = protein degradation Positive nitrogen balance protein synthesis > protein degradation Negative nitrogen balance protein synthesis < protein degradation UREA CYCLE Detoxification Of ammonia () REGULATION OF UREA CYCLE: N-Acetylglutamate is an essential activator for carbamoyl phosphate synthetase I—the rate-limiting step in the urea cycle N-Acetylglutamate is synthesized from acetyl coenzyme A and glutamate by N-acetylglutamate synthase in a reaction for which arginine is an activator. UREMIA urea and other waste products, are retained in the blood. Early symptoms include anorexia , lethargy ,fatigue, nausea, vomiting, cold, bone pain, itch, shortness of breath,, and late symptoms can include decreased mental acuity and coma. when the glomerular filtration rate, a measure of kidney function, is below 50% of normal.[2] Uremia can also result in uremic pericarditis. There are many dysfunctions caused by uremia affecting many systems of the body, such as blood (lower levels of erythropoietin), sex (lower levels of testosterone/estrogen), and bones (osteoporosis and metastatic calcifications). Uremia can also cause decreased peripheral conversion of T4 to T3, producing a functionally hypothyroid state. Azotemia: Refers to high levels of urea, but is used primarily when the abnormality can be measured chemically but is not yet so severe as to produce symptoms. Uremia is the pathological manifestations of severe azotemia. Hyperammonemia The capacity of the hepatic urea cycle exceeds the normal rates of ammonia generation . The levels of serum ammonia are normally low (5–35 μmol/L). CAUSES: liver function is compromised, due to genetic defects of the urea cycle or liver disease. blood levels can rise above 1,000 μmol/L. Such hy per ammon emia is a medical emergency, because ammonia has a direct neurotoxi effect on the CNS. .
Recommended publications
  • Novel Neuroprotective Compunds for Use in Parkinson's Disease
    Novel neuroprotective compounds for use in Parkinson’s disease A thesis submitted to Kent State University in partial Fulfillment of the requirements for the Degree of Master of Science By Ahmed Shubbar December, 2013 Thesis written by Ahmed Shubbar B.S., University of Kufa, 2009 M.S., Kent State University, 2013 Approved by ______________________Werner Geldenhuys ____, Chair, Master’s Thesis Committee __________________________,Altaf Darvesh Member, Master’s Thesis Committee __________________________,Richard Carroll Member, Master’s Thesis Committee ___Eric_______________________ Mintz , Director, School of Biomedical Sciences ___Janis_______________________ Crowther , Dean, College of Arts and Sciences ii Table of Contents List of figures…………………………………………………………………………………..v List of tables……………………………………………………………………………………vi Acknowledgments.…………………………………………………………………………….vii Chapter 1: Introduction ..................................................................................... 1 1.1 Parkinson’s disease .............................................................................................. 1 1.2 Monoamine Oxidases ........................................................................................... 3 1.3 Monoamine Oxidase-B structure ........................................................................... 8 1.4 Structural differences between MAO-B and MAO-A .............................................13 1.5 Mechanism of oxidative deamination catalyzed by Monoamine Oxidases ............15 1 .6 Neuroprotective effects
    [Show full text]
  • Lecture: 28 TRANSAMINATION, DEAMINATION and DECARBOXYLATION
    Lecture: 28 TRANSAMINATION, DEAMINATION AND DECARBOXYLATION Protein metabolism is a key physiological process in all forms of life. Proteins are converted to amino acids and then catabolised. The complete hydrolysis of a polypeptide requires mixture of peptidases because individual peptidases do not cleave all peptide bonds. Both exopeptidases and endopeptidases are required for complete conversion of protein to amino acids. Amino acid metabolism The amino acids not only function as energy metabolites but also used as precursors of many physiologically important compounds such as heme, bioactive amines, small peptides, nucleotides and nucleotide coenzymes. In normal human beings about 90% of the energy requirement is met by oxidation of carbohydrates and fats. The remaining 10% comes from oxidation of the carbon skeleton of amino acids. Since the 20 common protein amino acids are distinctive in terms of their carbon skeletons, amino acids require unique degradative pathway. The degradation of the carbon skeletons of 20 amino acids converges to just seven metabolic intermediates namely. i. Pyruvate ii. Acetyl CoA iii. Acetoacetyl CoA iv. -Ketoglutarate v. Succinyl CoA vi. Fumarate vii. Oxaloacetate Pyruvate, -ketoglutarate, succinyl CoA, fumarate and oxaloacetate can serve as precursors for glucose synthesis through gluconeogenesis.Amino acids giving rise to these intermediates are termed as glucogenic. Those amino acids degraded to yield acetyl CoA or acetoacetate are termed ketogenic since these compounds are used to synthesize ketone bodies. Some amino acids are both glucogenic and ketogenic (For example, phenylalanine, tyrosine, tryptophan and threonine. Catabolism of amino acids The important reaction commonly employed in the breakdown of an amino acid is always the removal of its -amino group.
    [Show full text]
  • Monoamine Oxidase Inhibitors: Promising Therapeutic Agents for Alzheimer's Disease (Review)
    MOLECULAR MEDICINE REPORTS 9: 1533-1541, 2014 Monoamine oxidase inhibitors: Promising therapeutic agents for Alzheimer's disease (Review) ZHIYOU CAI Department of Neurology, The Lu'an Affiliated Hospital of Anhui Medical University, Lu'an People's Hospital, Lu'an, Anhui 237005, P.R. China Received July 2, 2013; Accepted February 10, 2014 DOI: 10.3892/mmr.2014.2040 Abstract. Activated monoamine oxidase (MAO) has a critical 6. MAO activation contributes to cognitive impairment in role in the pathogenesis of Alzheimer's disease (AD), including patients with AD the formation of amyloid plaques from amyloid β peptide (Aβ) 7. Activated MAO contributes to the formation of amyloid production and accumulation, formation of neurofibrillary plaques tangles, and cognitive impairment via the destruction of cholin- 8. Is activated MAO associated with the formation of ergic neurons and disorder of the cholinergic system. Several neurofibrillary tangles? studies have indicated that MAO inhibitors improve cognitive 9. Evidence for the neuroprotective effect of MAO inhibitors deficits and reverse Aβ pathology by modulating proteolytic in AD cleavage of amyloid precursor protein and decreasing Aβ 10. Conclusions and outlook protein fragments. Thus, MAO inhibitors may be considered as promising therapeutic agents for AD. 1. Introduction Monoamine oxidase (MAO) catalyzes the oxidative deamina- Contents tion of biogenic and xenobiotic amines and has an important role in the metabolism of neuroactive and vasoactive amines in 1. Introduction the central nervous system (CNS) and peripheral tissues. The 2. Monoamine oxidase (MAO) enzyme preferentially degrades benzylamine and phenylethyl- 3. Involvement of MAO in neurodegeneration amine and targets a wide variety of specific neurotransmitters 4.
    [Show full text]
  • Transamination in Tumors, Fetal Tissues, and Regenerating Liver* Philip P
    Transamination in Tumors, Fetal Tissues, and Regenerating Liver* Philip P. Cohen, M.D., and G. Leverne Hekhuis (From the Laboratory o~ Physiological Chemistry, Yale University School of Medicine, New Haven, Connecticut) (Received for publication June 9, I94I) von Euler and co-workers (22), on the basis of TISSUE SOURCES results of essentially qualitative experiments, first re- Tumors.--The mouse tumors employed in this in- ported that the transaminase activity ot~ tumors was vestigation were the following: low. These investigators, using Jensen sarcoma and normal muscle, measured the rate of disappearance of I. United States Public Health Service No. ~7-- oxaloacetic acid in the following reaction: originally described as a neuroepithelioma (20). 1 2. Sarcoma 37 .1 3. Yale No. xuan estrogen-induced ,) 1( + )-glutamic acid + oxaloacetic acid a mammary adenocarcinoma (5). 1 4. No. x5o9I-A - ~'b a-ketoglutaric acid + aspartic acid spontaneous mammary medullary adenocarcinoma In addition to studies of reaction I in tumors, Braun- (6) "1 5- No. 42--glioblastoma multiforme. 2 6. No. stein and Azarkh (2) studied the reaction: i o8--rhabdomyosarcoma. 2 The tumors were transplanted at regular intervals 2) glutamic acid+a-keto acid to insure a uniform supply. a-ketoglutaric acid + amino acid "-b- Fetal, kitten, and adult cat tissues.--Two pregnant cats provided the fetal tissue. The length of the preg- The amino acids investigated in the case of reaction nancy was uncertain, but was estimated to be in the 2b were the d- and l-forms of alanine, valine, leucine, last trimester in both instances. Hemihysterectomies and isoleucine. The rate of reaction za in which both were performed under nembutal anesthesia and 2 d(--)- and l(+)-glutamic acid were used, plus fetuses removed from each animal.
    [Show full text]
  • Lecture 11 - Biosynthesis of Amino Acids
    Lecture 11 - Biosynthesis of Amino Acids Chem 454: Regulatory Mechanisms in Biochemistry University of Wisconsin-Eau Claire 1 Introduction Biosynthetic pathways for amino acids, Text nucleotides and lipids are very old Biosynthetic (anabolic) pathways share common intermediates with the degradative (catabolic) pathways. The amino acids are the building blocks for proteins and other nitrogen-containing compounds 2 2 Introduction Nitrogen Fixation Text Reducing atmospheric N2 to NH3 Amino acid biosynthesis pathways Regulation of amino acid biosynthesis. Amino acids as precursors to other biological molecules. e.g., Nucleotides and porphoryns 3 3 Introduction Nitrogen fixation is carried out by a few Text select anaerobic micororganisms The carbon backbones for amino acids come from glycolysis, the citric acid cycle and the pentose phosphate pathway. The L–stereochemistry is enforced by transamination of α–keto acids 4 4 1. Nitrogen Fixation Microorganisms use ATP and ferredoxin to Text reduce atmospheric nitrogen to ammonia. 60% of nitrogen fixation is done by these microorganisms 15% of nitrogen fixation is done by lighting and UV radiation. 25% by industrial processes Fritz Habers (500°C, 300!atm) N2 + 3 H2 2 N2 5 5 1. Nitrogen Fixation Enzyme has both a reductase and a Text nitrogenase activity. 6 6 1.1 The Reductase (Fe protein) Contains a 4Fe-4S Text center Hydrolysis of ATP causes a conformational change that aids the transfer of the electrons to the nitrogenase domain (MoFe protein) 7 7 1.1 The Nitrogenase (MoFe Protein) The nitrogenase Text component is an α2β2 tetramer (240#kD) Electrons enter the P-cluster 8 8 1.1 The Nitrogenase (MoFe Protein) An Iron-Molybdenum cofactor for the Text nitrogenase binds and reduces the atmospheric nitrogen.
    [Show full text]
  • Amino Acid Catabolism: Urea Cycle the Urea Bi-Cycle Two Issues
    BI/CH 422/622 OUTLINE: OUTLINE: Protein Degradation (Catabolism) Digestion Amino-Acid Degradation Inside of cells Urea Cycle – dealing with the nitrogen Protein turnover Ubiquitin Feeding the Urea Cycle Activation-E1 Glucose-Alanine Cycle Conjugation-E2 Free Ammonia Ligation-E3 Proteosome Glutamine Amino-Acid Degradation Glutamate dehydrogenase Ammonia Overall energetics free Dealing with the carbon transamination-mechanism to know Seven Families Urea Cycle – dealing with the nitrogen 1. ADENQ 5 Steps 2. RPH Carbamoyl-phosphate synthetase oxidase Ornithine transcarbamylase one-carbon metabolism Arginino-succinate synthetase THF Arginino-succinase SAM Arginase 3. GSC Energetics PLP uses Urea Bi-cycle 4. MT – one carbon metabolism 5. FY – oxidases Amino Acid Catabolism: Urea Cycle The Urea Bi-Cycle Two issues: 1) What to do with the fumarate? 2) What are the sources of the free ammonia? a-ketoglutarate a-amino acid Aspartate transaminase transaminase a-keto acid Glutamate 1 Amino Acid Catabolism: Urea Cycle The Glucose-Alanine Cycle • Vigorously working muscles operate nearly anaerobically and rely on glycolysis for energy. a-Keto acids • Glycolysis yields pyruvate. – If not eliminated (converted to acetyl- CoA), lactic acid will build up. • If amino acids have become a fuel source, this lactate is converted back to pyruvate, then converted to alanine for transport into the liver. Excess Glutamate is Metabolized in the Mitochondria of Hepatocytes Amino Acid Catabolism: Urea Cycle Excess glutamine is processed in the intestines, kidneys, and liver. (deaminating) (N,Q,H,S,T,G,M,W) OAA à Asp Glutamine Synthetase This costs another ATP, bringing it closer to 5 (N,Q,H,S,T,G,M,W) 29 N 2 Amino Acid Catabolism: Urea Cycle Excess glutamine is processed in the intestines, kidneys, and liver.
    [Show full text]
  • Amino&Acid&Metabolism& (Chapter&21)&
    BIOCH 765: Biochemistry II Spring 2014 Amino&Acid&Metabolism& (Chapter&21)& Jianhan&Chen& Office&Hour:&MF&1:30A2:30PM,&Chalmers&034& Email:&[email protected]& Office:&785A2518& Overview& • IntroducPon&to&amino&acids&and&proteins&(1)& • Protein&degradaPon&(1)& • Amino&acid&deaminaPon&(1)& • The&urea&cycle&(1)& • Breakdown&of&amino&acids&(2)& • Amino&acid&synthesis&(1)& • Nitrogen&fiXaPon&(1)& • Key&reference:&Chapter&21&& &&&&&of&Voet,&Voet&&&Pra\&(and& &&&&&this&lecture&note/google)& (c)&Jianhan&Chen& 2& Overview&of&Metabolism& • Metabolism is the sum/total of all the biochemical reactions that take place in a living organism. • Catabolism is all metabolic reactions in which large biochemical molecules are broken down to smaller ones, thus generating energy. • Anabolism is all metabolic reactions in which small biochemical molecules are joined to form larger ones through consumption of energy. catabolism + energy anabolism 3 Major&Stages&of&Catabolism& 4 Insert: macromolecule anabolism Plants start with Biosynthetic pathways always differ from catabolic pathways. 5 Summary of Protein/Amino Acid Body Proteins (protein turnover) Metabolism Amino alcohols Hormones Heme Dietary Proteins Amino Acids Purines (digestion) Pyrimidines degradation Neurotransmitters Nucleotides Glucose + Pyruvate Carbon skeletons NH4 Urea Acetyl Citric Acid cholesterol ATP CoA cycle Fatty acids Ketone bodies 6 Chapter&21&A&1& 1.#PROTEIN#DEGRADATION# Key#Concepts#21.1## •&EXtracellular&and&intracellular&proteins&may&be&digested&by&lysosomal&proteases.& •&Other&proteins&to&be&degraded&are&first&conjugated&to&the&protein&ubiquiPn.&
    [Show full text]
  • Identification of Novel Monoamine Oxidase B Inhibitors from Ligand Based Virtual Screening
    Identification of novel monoamine oxidase B inhibitors from ligand based virtual screening A thesis submitted to Kent State University in partial Fulfillment of the requirements for the Degree of Master of Science By Mohammed Alaasam August, 2014 Thesis written by Mohammed Alaasam B.S., University of Baghdad, 2007 M.S., Kent State University, 2014 Approved by Werner Geldenhuys , Chair, Master’s Thesis Committee Richard Carroll , Member, Master’s Thesis Committee Prabodh Sadana , Member, Master’s Thesis Committee Eric Mintz , Director, School of Biomedical Sciences James Blank , Dean, College of Arts and Sciences ii Table of Contents List of figure ...................................................................................................................... vi List of tables ..................................................................................................................... xiii Acknowledgments............................................................................................................ xiv Chapter one: Introduction ............................................................................................... 1 1.1.Parkinson's disease ....................................................................................................... 1 1.2.Monoamine oxidase enzymes ....................................................................................... 7 1.3.Structures of MAO enzymes ....................................................................................... 12 1.4.Three dimentiona
    [Show full text]
  • Monoamine Oxidase and Semicarbazide-Sensitive Amine Oxidase Kinetic Analysis in Mesenteric Arteries of Patients with Type 2 Diabetes
    Physiol. Res. 60: 309-315, 2011 https://doi.org/10.33549/physiolres.931982 Monoamine Oxidase and Semicarbazide-Sensitive Amine Oxidase Kinetic Analysis in Mesenteric Arteries of Patients With Type 2 Diabetes S. F. NUNES1, I. V. FIGUEIREDO1, 3, J. S. PEREIRA2, E. T. DE LEMOS3, F. REIS3, F. TEIXEIRA3, M. M. CARAMONA1 1Laboratory of Pharmacology, Faculty of Pharmacy, Coimbra University, Coimbra, Portugal, 2Portuguese Oncology Institute of Coimbra, Portugal, 3Institute of Pharmacology and Experimental Therapeutics, IBILI, Faculty of Medicine, Coimbra University, Coimbra, Portugal Received February 22, 2010 Accepted August 30, 2010 On-line November 29, 2010 Summary Corresponding author Monoamine oxidase (MAO, type A and B) and semicarbazide- M. M. Caramona, Laboratory of Pharmacology, Faculty of sensitive amine oxidase (SSAO) metabolize biogenic amines, Pharmacy, Coimbra University, 3000-548, Coimbra, Portugal. however, the impact of these enzymes in arteries from patients Fax: +351 239 488 503. E-mail: [email protected] with type 2 diabetes remains poorly understood. We investigated the kinetic parameters of the enzymes to establish putative correlations with noradrenaline (NA) content and patient age in Introduction human mesenteric arteries from type 2 diabetic patients. The kinetic parameters were evaluated by radiochemical assay and Oxidative stress can be defined as a disturbance NA content by high-performance liquid chromatography (HPLC). in the balance between the production of free radicals – The activity of MAO-A and SSAO in type 2 diabetic vascular such as superoxide anion, hydroxyl radicals and hydrogen tissues was significantly lower compared to the activity obtained peroxide – and antioxidant mechanisms (Ramakrishna in non-diabetic tissues. In the correlation between and Jailkhani 2008).
    [Show full text]
  • Transamination What Is Transamination? Subhadipa 2020 • Important Method of Nitrogen Metabolism of Amino Acids
    Subhadipa 2020 Transamination What is Transamination? Subhadipa 2020 • Important method of nitrogen metabolism of amino acids. • Transamination is the transfer of an amine group from an amino acid to a keto acid (amino acid without an amine group), thus creating a new amino acid and keto acid. • Transamination reactions combine reversible amination and deamination, and they mediate redistribution of amino groups among amino acids. • Transaminases (aminotransferases) are widely distributed in human tissues and are particularly active in heart muscle, liver, skeletal muscle, and kidney. • The general reaction of transamination is: Concerned enzyme • The reaction is catalyzed by transaminase or amino transferase. • Enzymes act on L-amino acid but not on D-isomers. • They occur both mitochondria and cytosol as separate enzyme. • There are many transferases, each acts on a particular amino acid and a particular keto acid. Amino and keto acid • All naturally occurring amino acids undergo transamination. • Exceptions include basic amino acids lysine, hydroxyl amino acids, serine and threonine and heterocyclic amino acids proline and hydroxyl-proline. • Keto acids like pyruvic acid, oxaloacetic acid and α- ketoglutaric acid are commonly involved. • Glyoxylate and glutamic γ semialdehyde may also act as amino- receptors in transamination. E-PLP Complex Subhadipa 2020 All transaminase reactions have the same mechanism and use pyridoxal phosphate (a derivative of vitamin B6). Pyridoxal phosphate is linked to the enzyme by formation of a Schiff base between its aldehyde group and the ε-amino group of a specific lysyl residue at the active site and held noncovalently through its positively charged nitrogen atom and the negatively charged phosphate group.
    [Show full text]
  • Amino Acid Metabolism. General Pathways of Transformation of Amino Acids
    Ministry of Public Health of Ukraine Ukrainian Medical Stomatological Academy Department of biological and bioorganic chemistry Amino acid metabolism. General pathways of transformation of amino acids. Ammonia metabolism: biosynthesis of urea and its disorders. Assoc. Prof. Bilets M.V. Lecture plan • The general pathways of amino acids metabolism: - Decarboxylation of amino acids. - Transamination of amino acids - Direct and indirect deamination of amino acids. • Pathways of ammonia formation. • The molecular mechanisms of ammonia toxicity. • The molecular mechanisms of ammonia detoxification. Amino acid, any of a group of organic molecules that consist of a basic amino group (―NH2), an acidic carboxyl group (―COOH), and an organic R group (or side chain) that is unique to each amino acid. The term amino acid is short for α-amino [alpha-amino] carboxylic acid. Each molecule contains a central carbon (C) atom, called the α- carbon, to which both an amino and a carboxyl group are attached. The remaining two bonds of the α-carbon atom are generally satisfied by a hydrogen (H) atom and the R group. The formula of a general amino acid is: 1.The amino acids are used by various tissues to synthesize proteins and to produce nitrogen-containing compounds (e.g., purines, heme, creatine, epinephrine), or they are oxidized to produce energy. 2.The breakdown of both dietary and tissue proteins yields nitrogen-containing substrates and carbon skeletons. 3.The nitrogen-containing substrates are used in the biosynthesis of purines, pyrimidines, neurotransmitters, hormones, porphyrins, and nonessential amino acids. 4.The carbon skeletons are used as a fuel source in the citric acid cycle, used for gluconeogenesis, or used in fatty acid synthesis.
    [Show full text]
  • Amino Acid Catabolism
    Amino Acid Catabolism • Dietary Proteins • Turnover of Protein • Cellular protein • Deamination • Urea cycle • Carbon skeletons of amino acids Amino Acid Metabolism •Metabolism of the 20 common amino acids is considered from the origins and fates of their: (1) Nitrogen atoms (2) Carbon skeletons •For mammals: Essential amino acids must be obtained from diet Nonessential amino acids - can be synthesized Amino Acid Catabolism • Amino acids from degraded proteins or from diet can be used for the biosynthesis of new proteins • During starvation proteins are degraded to amino acids to support glucose formation • First step is often removal of the α-amino group • Carbon chains are altered for entry into central pathways of carbon metabolism Dietary Proteins • Digested in intestine • by peptidases • transport of amino acids • active transport coupled with Na+ Protein Turnover • Proteins are continuously synthesized and degraded (turnover) (half-lives minutes to weeks) • Lysosomal hydrolysis degrades some proteins • Some proteins are targeted for degradation by a covalent attachment (through lysine residues) of ubiquitin (C terminus) • Proteasome hydrolyzes ubiquitinated proteins Turnover of Protein • Cellular protein • Proteasome degrades protein with Ub tags • T 1/2 determined by amino terminus residue • stable: ala, pro, gly, met greater than 20h • unstable: arg, lys, his, phe 2-30 min Ubibiquitin • Ubiquitin protein, 8.5 kD • highly conserved in yeast/humans • carboxy terminal attaches to ε-lysine amino group • Chains of 4 or more Ub molecules
    [Show full text]